Form 4 for SRTA Strata Critical Medical, Inc.
Accepted 2025-10-23 00:00:00 ET · period of report 2025-10-22 · accession 0001628280-25-046085 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-10-23 | 2025-10-22 | SRTA | Tomkiel Melissa M. | GC, Co-CEO, Dir | M - OptEx | $0.18 | +55.6K | 1.27M | +5% | +$10.0K |
| D | 2025-10-23 | 2025-10-22 | SRTA | Tomkiel Melissa M. | GC, Co-CEO, Dir | M - OptEx | $0.00 | -55.6K | 304.7K | -15% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A common stock, $0.0001 par value per share | 2025-10-22 | M | A | 55,556 | $0.18 | 1,270,372 | D | — | — | |
| 2 | Derivative | Stock Option (right to buy) | 2025-10-22 | M | D | 55,556 | $0.00 | 304,738 | D | $0.18 · 2021-05-07 to 2030-07-28 | 55,556 Class A common stock, $0.0001 par value per share |